← Open Payments lookup

MIRABELLA MULLER: Open Payments

NPI 1497230320 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,274 in 40 payments from 14 companies in 2025. Trend: 2023 $1,562 · 2024 $1,659 · 2025 $1,274

Food & beverage: $1,274
CompanyPaymentsAmount
Amgen Inc.6$222
Incyte Corporation2$181
GENZYME CORPORATION5$147
ABBVIE INC.8$146
Botanix SB Inc1$100
SUN PHARMACEUTICAL INDUSTRIES INC.1$93
UCB, Inc.4$89
Novartis Pharmaceuticals Corporation3$84
PFIZER INC.3$60
Janssen Biotech, Inc.2$45

Products named: OTEZLA, OPZELURA, DUPIXENT, SOFDRA, SKYRIZI, Bimzelx, COSENTYX, CIBINQO.

Industry payments across DC — which companies pay providers there.